Month: September 2024

New Peer-Reviewed Study Uncovers How AI-Powered Approach Accurately Stratifies Risk for Senior Polypharmacy Patients and Delivers Appropriate Medication Recommendations

Published in The American Journal of Managed Care, findings from researchers at major US hospital demonstrate how FeelBetter's AI-powered platform...

IntegriChain and Federal Compliance Solutions Experts to Speak on the Intricacies Inflation Reduction Act at MDRP Summit

PHILADELPHIA, Sept. 10, 2024 /PRNewswire/ -- IntegriChain, the leading provider of pharma revenue optimization technology and insights for the pharmaceutical industry,...

The Human Trust and Dionysus Health Present: ‘The Future is Hers: Investing in Women’s Health’ Luncheon at the Delegates Dining Room at the United Nations

Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma

Soquelitinib is a potential first-in-class ITK inhibitor with broad potential in cancer and immune diseases There are currently no fully...

error: Content is protected !!